Osiris Therapeutics, Inc., the leading wound care medicines, cellular and regenerative medicine firm, has announced first quarter 2015 financial results.
The results shows revenue was $21.0 million Up by 109% YoY, while EPS also improved from -$0.02 to $0.04.
View the full earnings release here.